Miguel A, Azevedo LF, Araújo M, et al. Frequency of adverse drug reactions in hospitalized patients: a systematic review and meta-analysis. Pharmacoepidemiol Drug Saf. 2012;21(11):1139–54.

Article  Google Scholar 

Bouvy JC, De Bruin ML, Koopmanschap MA. Epidemiology of adverse drug reactions in Europe: a review of recent observational studies. Drug Saf. 2015;38(5):437–53.

Article  CAS  Google Scholar 

Hsu CY, Cheng CY, Lee JD, et al. Effects of long-term anti-seizure medication monotherapy on all-cause death in patients with post-stroke epilepsy: a nationwide population-based study in Taiwan. BMC Neurol. 2021;21:226.

Article  CAS  Google Scholar 

George J, Kulkarni C, Sarma GRK. Antiepileptic drugs and quality of life in patients with epilepsy: a tertiary care hospital-based study. Value Health Reg Issues. 2015;6:1–6.

Article  Google Scholar 

Perucca P, Gilliam FG. Adverse effects of antiepileptic drugs. Lancet Neurol. 2012;11(9):792–802.

Article  CAS  Google Scholar 

Du Y, Lin J, Shen J, et al. Adverse drug reactions associated with six commonly used antiepileptic drugs in southern China from 2003 to 2015. BMC Pharmacol Toxicol. 2019;20:7.

Article  Google Scholar 

Maqbool M, Dugassa D, Fekadu G. Adverse drug reactions of antiepileptic drugs in the neurology department of a tertiary care hospital, Srinagar, Jammu & Kashmir, India. Arch Neurosci. 2021. https://doi.org/10.5812/ans.112364.

Article  Google Scholar 

Health Product Vigialnce Center. Overview of Drug Adverse Event 1984–2020. 2020. https://hpvcth.fda.moph.go.th/wp-content/uploads/hpvc_2021_06_08_154159.pdf. Accessed 5 Mar 2023.

Hazell L, Shakir SAW. Under-reporting of adverse drug reactions: a systematic review. Drug Saf. 2006;29(5):385–96.

Article  Google Scholar 

Blenkinsopp A, Wilkie P, Wang M, et al. Patient reporting of suspected adverse drug reactions: a review of published literature and international experience. Br J Clin Pharmacol. 2007;63(2):148–56.

Article  CAS  Google Scholar 

van Hunsel F, Härmark L, Pal S, et al. Experiences with adverse drug reaction reporting by patients: an 11-country survey. Drug Saf. 2012;35:45–60.

Article  Google Scholar 

Shafei L, Mekki L, Maklad E, et al. Factors that influence patient and public adverse drug reaction reporting: a systematic review using the theoretical domains framework. Int J Clin Pharm. 2023;45(4):801–13.

Article  Google Scholar 

Krska J, Jones L, Mckinney J, et al. Medicine safety: experiences and perceptions of the general public in Liverpool. Pharmacoepidemiol Drug Saf. 2011;20(10):1098–103.

Article  Google Scholar 

de Langen J, van Hunsel F, Passier A, et al. Adverse drug reaction reporting by patients in the Netherlands: three years of experience. Drug Saf. 2008;31(6):515–24.

Article  Google Scholar 

Al Dweik R, Stacey D, Kohen D, et al. Factors affecting patient reporting of adverse drug reactions: a systematic review. Br J Clin Pharmacol. 2017;83(4):875–83.

Article  Google Scholar 

Adedeji-Adenola H, Nlooto M. Direct reporting of adverse drug reactions by healthcare consumers in Africa: a narrative review. Int J Clin Pharm. 2021;43:11–24.

Article  Google Scholar 

Levy M, Azaz-Livshits T, Sadan B, et al. Computerized surveillance of adverse drug reactions in hospital: implementation. Eur J Clin Pharmacol. 1999;54(11):887–92.

Article  CAS  Google Scholar 

Bagheri H, Michel F, Lapeyre-Mestre M, et al. Detection and incidence of drug-induced liver injuries in hospital: a prospective analysis from laboratory signals. Br J Clin Pharmacol. 2000;50(5):479–84.

Article  CAS  Google Scholar 

Warner A, Privitera M, Bates D. Standards of laboratory practice: antiepileptic drug monitoring. Clin Chem. 1998;44(5):1085–95.

Article  CAS  Google Scholar 

Patsalos PN, Spencer EP, Berry DJ. Therapeutic drug monitoring of antiepileptic drugs in epilepsy: a 2018 update. Ther Drug Monit. 2018;40(5):526–48.

Article  CAS  Google Scholar 

Valinciute-Jankauskiene A, Kubiliene L. Adverse drug reaction reporting by patients in 12 European countries. Int J Environ Res Public Health. 2021;18(4):1507.

Article  Google Scholar 

Chaipichit N, Krska J, Pratipanawatr T, et al. Statin adverse effects: patients’ experiences and laboratory monitoring of muscle and liver injuries. Int J Clin Pharm. 2015;37(2):355–64.

Article  CAS  Google Scholar 

Jarernsiripornkul N, Senacom P, Uchaipichat V, et al. Patient reporting of suspected adverse drug reactions to antiepileptic drugs: factors affecting attribution accuracy. Epilepsy Behav. 2012;24:102–6.

Article  Google Scholar 

Jarernsiripornkul N, Chaipichit N, Pratipanawatr T, et al. Initial development and testing of an instrument for patient self-assessment of adverse drug reactions. Pharmacoepidemiol Drug Saf. 2016;25:54–63.

Article  Google Scholar 

Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30(2):239–45.

Article  CAS  Google Scholar 

Longo DL, Fauci AS, Kasper DL, et al. Harrison’s principles of internal medicine. 18th ed. New York: McGraw-Hill; 2012. (ISBN: 978-0-071-74887-2).

Google Scholar 

DiPiro JT, Talbert RL, Yee GC, et al. Pharmacotherapy: a pathophysiologic approach. 9th ed. New York: McGraw-Hill; 2014. (ISBN 978-0-071-85052-0).

Google Scholar 

American Society of Health-System Pharmacists. AHFS drug information. Bethesda; 2014 (ISBN 978-1-585-28380-4).

Aronson JK. Meyler’s side effects of drugs—the international encyclopedia of adverse drug reactions and interactions. Amsterdam: Elsevier; 2015. (ISBN 978-0-444-53716-4).

Google Scholar 

Lertsinudom S, Nuntasaen T, Pranboon S, et al. Adverse drug reactions of antiepileptic drugs in epilepsy clinic. Srinagarind Hosp J Med Assoc Thai. 2019;102(Suppl 3):1–5.

Google Scholar 

Ayalew MB, Muche EA. Patient reported adverse events among epileptic patients taking antiepileptic drugs. SAGE Open Med. 2018;6:2050312118772471.

Article  Google Scholar 

Namazi S, Borhani-Haghighi A, Karimzadeh I. Adverse reactions to antiepileptic drugs in epileptic outpatients: a cross-sectional study in iran. Clin Neuropharmacol. 2011;34(2):79–83.

Article  CAS  Google Scholar 

Jarernsiripornkul N, Chaisrisawadsuk S, Chaiyakum A, et al. Patient self-reporting of potential adverse drug reactions to non-steroidal anti-inflammatory drugs in Thailand. Pharm World Sci. 2009;31(5):559–64.

Article  CAS  Google Scholar 

Bent S, Padula A, Avins AL. Brief communication: better ways to question patients about adverse medical events: a randomized, controlled trial. Ann Intern Med. 2006;144(4):257–61.

Article  Google Scholar 

Bryant AE, Dreifuss FE. Hepatotoxicity associated with antiepileptic drug therapy. CNS Drugs. 1995;4:99–113. https://doi.org/10.2165/00023210-199504020-00003.

Article  CAS  Google Scholar 

Tolou-Ghamari Z, Zare M, Habibabadi JM, et al. Antiepileptic drugs: a consideration of clinical and biochemical outcome in patients with epilepsy. Int J Prev Med. 2013;4(Suppl 2):S330–7.

Google Scholar 

Hanaya R, Arita K. The new antiepileptic drugs: their neuropharmacology and clinical indications. Neurol Med Chir. 2016;56(5):205–20.

Article  Google Scholar 

Moavero R, Pisani LR, Pisani F, et al. Safety and tolerability profile of new antiepileptic drug treatment in children with epilepsy. Expert Opin Drug Saf. 2018;17(10):1015–28.

Article  CAS  Google Scholar 

Hilgers A, Schaefer M. Systematic adverse drug reaction monitoring of patients under newer antiepileptic drugs using routine clinical data of inpatients. Drugs Real World Outcomes. 2016;3(2):209–21.

Article  Google Scholar 

Roopa BS, Narayan SS, Sharma GRK, et al. Pattern of adverse drug reactions to antiepileptic drugs: a cross-sectional one-year survey at a tertiary care hospital. Pharmacoepidemiol Drug Saf. 2008;17(8):807–12.

Article  Google Scholar 

Patsalos PN, Berry DJ, Bourgeois BFD, et al. Antiepileptic drugs - Best practice guidelines for therapeutic drug monitoring: a position paper by the subcommission on therapeutic drug monitoring, ILAE Commission on Therapeutic Strategies. Epilepsia. 2008;49(7):1239–76.

Article  CAS  Google Scholar 

Rolfes L, van Hunsel F, Wilkes S, et al. Adverse drug reaction reports of patients and healthcare professionals-differences in reported information. Pharmacoepidemiol Drug Saf. 2015;24(2):152–8.

Article  Google Scholar 

Chaipichit N, Krska J, Pratipanawatr T, et al. A qualitative study to explore how patients identify and assess symptoms as adverse drug reactions. Eur J Clin Pharmacol. 2014;70(5):607–15.

Article  CAS  Google Scholar 

Kampichit S, Pratipanawatr T, Jarernsiripornkul N. Severity of adverse drug reactions by patient self-reporting. Srinagarind Med J. 2018;33(2):113–21.

Google Scholar 

Narumol J, Arunrot P, Krska J. Survey of patients’ experiences and their certainty of suspected adverse drug reactions. Int J Clin Pharm. 2015;37:168–74.

Article  CAS  Google Scholar 

Uijl SG, Uiterwaal CSMP, Aldenkamp AP, et al. A cross-sectional study of subjective complaints in patients with epilepsy who seem to be well-controlled with antiepileptic drugs. Seizure. 2006;15(4):242–8.

Article  CAS  Google Scholar